| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/04/1993 | EP0553088A1 Promotion of maturation of hematopoietic progenitor cells |
| 08/04/1993 | EP0510073B1 Method for increasing fertility in males |
| 08/04/1993 | EP0417193B1 Freeze-dried formulation for antibody products |
| 08/04/1993 | EP0377044B1 Protective agent for radiation hazard |
| 08/04/1993 | EP0355095B1 Pharmacological agent-lipid solution preparation |
| 08/04/1993 | CN1074903A Substituted hexahyhdroazepinones and tetrahydrobenzazepinones |
| 08/04/1993 | CN1074825A Delayed release device for transition metal/protein complexes |
| 08/04/1993 | CA2107461A1 Remedy for dermatopathy and metallothionein inducer |
| 08/03/1993 | US5232913 Liver disorders, hepatitis disease |
| 08/03/1993 | US5232912 Anticoagulant peptides |
| 08/03/1993 | US5232911 Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent |
| 08/03/1993 | US5232847 Anticoagulants, longer half life |
| 08/03/1993 | US5232841 Expression vectors containing a bacillus brevis signal sequence |
| 08/03/1993 | US5232708 Polyvinyl alcohol for sustained release of bioactive material |
| 08/03/1993 | US5232696 Immobilizing phospholipase, contacting with blood to hydrolyze glycerophospholipid for rapid metabolism |
| 08/03/1993 | US5232695 Administering alone or with an antiviral agent |
| 08/03/1993 | CA1320906C Interleukin-2 induced antineoplastic peptide |
| 08/03/1993 | CA1320905C Treatment of immuno-resistant disease |
| 08/03/1993 | CA1320904C Method for the treatment of atherosclerosis, thrombosis and peripheral vessel disease |
| 08/01/1993 | WO1993014775A1 Monoclonal antibody pd41 and antigen associated with prostate adenocarcinomas |
| 08/01/1993 | CA2106487A1 Monoclonal antibody pd41 and antigen associated with prostate adenocarcinomas |
| 07/31/1993 | CA2088390A1 Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them |
| 07/31/1993 | CA2087504A1 Administration of low dose hemoglobin to increase perfusion |
| 07/28/1993 | EP0552999A1 Hirudin derivatives |
| 07/28/1993 | EP0552878A2 Molecules for iontophoretic delivery |
| 07/28/1993 | EP0552850A1 Cloning and expression of HTLV-III DNA |
| 07/28/1993 | EP0552516A1 Aqueous synthetic organ-extracts |
| 07/28/1993 | EP0552489A2 Peptide, production and use thereof |
| 07/28/1993 | EP0552342A1 Method for inhibiting blood coagulant activity |
| 07/28/1993 | EP0552309A1 New process for biophosphorylating organic compounds |
| 07/28/1993 | EP0552302A1 Method of inhibiting transcription utilizing nuclear receptors |
| 07/28/1993 | EP0552296A1 Mouse monoclonal antibodies |
| 07/28/1993 | EP0552257A1 A plant protein useful for treating tumors and hiv infection |
| 07/28/1993 | EP0552256A1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 07/28/1993 | EP0552247A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
| 07/28/1993 | EP0552238A1 Cyclopeptides, a method of preparing them, and their use as drugs |
| 07/28/1993 | EP0552202A1 FUNCTIONAL ANTAGONISM BETWEEN PROTO-ONCOPROTEIN c-JUN AND HORMONE RECEPTORS. |
| 07/28/1993 | EP0552188A1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
| 07/28/1993 | EP0552142A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 07/28/1993 | EP0531442A4 Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty |
| 07/28/1993 | EP0528861A4 Composition and treatment with biologically active peptides and toxic cations |
| 07/28/1993 | EP0495014A4 Novel oxidized lipoproteins and methods for their preparation |
| 07/28/1993 | EP0432199B1 Composition for the treatment of erectile dysfunction |
| 07/28/1993 | EP0381696B1 Pharmaceutical composition for the treatment of cocaine addiction |
| 07/28/1993 | CA2107097A1 Icam-related protein |
| 07/27/1993 | US5231216 Trans-2-acylaminocyclohexyloxyacyldipeptides in the form of mixtures of diastereoisomers thereof and in the form of pure diasteredisomers, process for the preparation thereof and pharmaceutical compositions containing the same |
| 07/27/1993 | US5231176 Distinct family DNA encoding of human leukocyte interferons |
| 07/27/1993 | US5231168 Malaria antigen |
| 07/27/1993 | US5231167 Immunoglobulin-binding polypeptides |
| 07/27/1993 | US5231166 Endothelin |
| 07/27/1993 | US5231084 ACE inhibitor |
| 07/27/1993 | US5231083 Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia |
| 07/27/1993 | US5231082 Cyclic peptide with anti-metastasis activity |
| 07/27/1993 | US5231081 Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors |
| 07/27/1993 | US5231080 Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease |
| 07/27/1993 | US5231026 DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE |
| 07/27/1993 | US5231013 Staphylococcus biosynthesis |
| 07/27/1993 | US5231012 Genes and proteins |
| 07/27/1993 | US5231010 Deletion of proline or addition of alanine-glutamine to arginine transforming S. cerevisiae vector |
| 07/27/1993 | US5231009 Cdnas coding for members of the carcinoembryonic antigen family |
| 07/27/1993 | US5231003 Monoclonal antibodies specific for toxin b of clostridium difficile |
| 07/27/1993 | US5231002 Synthetic SCM-active cancer recognition peptides |
| 07/27/1993 | US5231001 Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 07/27/1993 | US5230902 Undenatured whey protein concentrate to improve active systemic humoral immune response |
| 07/27/1993 | US5230886 Tumor cell suppression |
| 07/27/1993 | US5230884 Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
| 07/27/1993 | CA1320682C Diagnostic probes for detecting elastase modified antithrombin and methods of treatment |
| 07/22/1993 | WO1993014406A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 07/22/1993 | WO1993014220A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | WO1993014208A2 Hepatitis e virus vaccine and method |
| 07/22/1993 | WO1993014206A2 Synthetic peptides for a rubella vaccine |
| 07/22/1993 | WO1993014203A1 Lymphotoxins, expression vector therefor, and production of lymphotoxins with said vector |
| 07/22/1993 | WO1993014202A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 07/22/1993 | WO1993014201A1 Dna encoding a human 5-ht1f receptor and uses thereof |
| 07/22/1993 | WO1993014199A1 A pump-1 catalyzed method of making low molecular weight urokinase-type plasminogen activator |
| 07/22/1993 | WO1993014198A1 Multifunctional surface protein of streptococci |
| 07/22/1993 | WO1993014193A1 Genetically engineered endothelial cells |
| 07/22/1993 | WO1993014125A1 Novel lymphocytic antigen, corresponding antibody and applications thereof |
| 07/22/1993 | WO1993014124A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | WO1993014123A1 A novel human kunitz-type protease inhibitor and variants thereof |
| 07/22/1993 | WO1993014122A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014121A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014120A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014119A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | WO1993014116A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | WO1993014115A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/22/1993 | WO1993014114A1 Peptide linkage unit comprising methylene phosphinic acid |
| 07/22/1993 | WO1993014113A1 Peptides with tachykinin antagonist activity |
| 07/22/1993 | WO1993014111A1 Novel compound ustiloxin a or b, or derivative thereof |
| 07/22/1993 | WO1993014098A1 Antigen recognized by patients with antibody associated lambert-eaton myasthenic syndrome (lems), dna encoding same and uses thereof |
| 07/22/1993 | WO1993013806A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013799A1 Methods of terminating pregnancy |
| 07/22/1993 | WO1993013798A1 Treatment for asthma |
| 07/22/1993 | WO1993013796A1 Enzyme castration of animals and tumor treatment |
| 07/22/1993 | WO1993013795A1 Medical use, a medical method and a pharmaceutical preparation |
| 07/22/1993 | WO1993013794A1 Novel methods and compositions for treatment of angiogenic diseases |
| 07/22/1993 | WO1993013793A1 Pharmaceutical bacteriocin compositions |
| 07/22/1993 | WO1993013792A1 Delayed release device for transition metal/protein complexes |
| 07/22/1993 | WO1993013791A1 Use of muramyl peptides for enhancing animal production |